Tumor dose response to the vascular disrupting agent, 5,6-dimethylxanthenone-4-acetic acid, using in vivo magnetic resonance spectroscopy.
about
Non-invasive in vivo imaging of early metabolic tumor response to therapies targeting choline metabolism.The response of RIF-1 fibrosarcomas to the vascular-disrupting agent ZD6126 assessed by in vivo and ex vivo 1H magnetic resonance spectroscopy.Multiparametric MRI biomarkers for measuring vascular disrupting effect on cancerRat tumor response to the vascular-disrupting agent 5,6-dimethylxanthenone-4-acetic acid as measured by dynamic contrast-enhanced magnetic resonance imaging, plasma 5-hydroxyindoleacetic acid levels, and tumor necrosis.Control of cervicovaginal HPV-16 E7-expressing tumors by the combination of therapeutic HPV vaccination and vascular disrupting agentsIn vivo monitoring response to chemotherapy of human diffuse large B-cell lymphoma xenografts in SCID mice by 1H and 31P MRSNoninvasive magnetic resonance spectroscopic pharmacodynamic markers of a novel histone deacetylase inhibitor, LAQ824, in human colon carcinoma cells and xenograftsTherapeutic targets and biomarkers identified in cancer choline phospholipid metabolism.The potential of DMXAA (ASA404) in combination with docetaxel in advanced prostate cancer.In vivo small animal imaging: current status and future prospects.N-(4-iodophenyl)-N'-(2-chloroethyl)urea as a microtubule disrupter: in vitro and in vivo profiling of antitumoral activity on CT-26 murine colon carcinoma cell line cultured and grafted to mice.The effects of the vascular disrupting agents combretastatin A-4 disodium phosphate, 5,6-dimethylxanthenone-4-acetic acid and ZD6126 in a murine tumour: a comparative assessment using MRI and MRS.
P2860
Q31027315-38F4390D-C4BF-4D2D-93C0-8408351B10DFQ31049713-053AA001-186D-44B8-AEE7-83FD4354C8F2Q34538659-7FFD8381-2D1A-4D4B-91DF-B0B46E89CC2BQ35052189-14A58398-5AC2-48C9-BB38-49C15AD04EA4Q35102014-56CC972A-CA3E-475B-A53B-4489D06CBFBCQ36289235-A7D10459-80F8-48D9-9BC6-9CF83EEE5A2BQ36528232-93681DC1-6DF7-4326-814D-283B967D8911Q36630017-0F2AE4CB-3E28-499E-B02C-2BA2388BFAB8Q37038979-24AA4CE4-EC92-4354-8160-C5D8B3002005Q37837837-D83D6616-F38A-424D-AAA2-9F5D35EEEB49Q40135845-D5D4A561-68F3-4962-AEDE-04B257AA94B0Q51808119-7AC76FE1-B0E7-4CE4-A229-BECD4904341B
P2860
Tumor dose response to the vascular disrupting agent, 5,6-dimethylxanthenone-4-acetic acid, using in vivo magnetic resonance spectroscopy.
description
2005 nî lūn-bûn
@nan
2005 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Tumor dose response to the vas ...... gnetic resonance spectroscopy.
@ast
Tumor dose response to the vas ...... gnetic resonance spectroscopy.
@en
type
label
Tumor dose response to the vas ...... gnetic resonance spectroscopy.
@ast
Tumor dose response to the vas ...... gnetic resonance spectroscopy.
@en
prefLabel
Tumor dose response to the vas ...... gnetic resonance spectroscopy.
@ast
Tumor dose response to the vas ...... gnetic resonance spectroscopy.
@en
P2093
P1476
Tumor dose response to the vas ...... gnetic resonance spectroscopy.
@en
P2093
Basetti Madhu
John R Griffiths
Lesley D McPhail
Lloyd R Kelland
Simon Clark
Simon P Robinson
Yuen-Li Chung
P304
P356
10.1158/1078-0432.CCR-04-2504
P407
P577
2005-05-01T00:00:00Z